Abstract:Abstract Background As the novel coronavirus triggering COVID-19 has broken out in Wuhan, China and spread rapidly worldwide, it threatens the lives of thousands of people and poses a global threat on the economies of the entire world. However, infection with COVID-19 is currently rare in children. Objective To discuss the latest findings and research focus on the basis of characteristics of children confirmed with COVID-19, and provide an insight into the future treatment and research direction. Methods We searched the terms “COVID-19 OR coronavirus OR SARS-CoV-2” AND “Pediatric OR children” on PubMed, Embase, Cochrane library, NIH, CDC, and CNKI. The authors also reviewed the guidelines published on Chinese CDC and Chinese NHC. Results We included 25 published literature references related to the epidemiology, clinical manifestation, accessary examination, treatment, and prognosis of pediatric patients with COVID-19. Conclusion The numbers of children with COVID-19 pneumonia infection are small, and most of them come from family aggregation. Symptoms are mainly mild or even asymptomatic, which allow children to be a risk factor for transmission. Thus, strict epidemiological history screening is needed for early diagnosis and segregation. This holds especially for infants, who are more susceptible to infection than other age groups in pediatric age, but have most likely subtle and unspecific symptoms. They need to be paid more attention to. CT examination is a necessity for screening the suspected cases, because most of the pediatric patients are mild cases, and plain chest X-ray do not usually show the lesions or the detailed features. Therefore, early chest CT examination combined with pathogenic detection is a recommended clinical diagnosis scheme in children. The risk factors which may suggest severe or critical progress for children are: Fast respiratory rate and/or; lethargy and drowsiness mental state and/or; lactate progressively increasing and/or; imaging showed bilateral or multi lobed infiltration, pleural effusion or rapidly expending of lesions in a short period of time and/or; less than 3 months old or those who underly diseases. For those critical pediatric patients with positive SARS-CoV-2 diagnosis, polypnea may be the most common symptom. For treatment, the elevated PCT seen in children in contrast to adults suggests that the underlying coinfection/secondary infection may be more common in pediatric patients and appropriate antibacterial treatment should be considered. Once cytokine storm is found in these patients, anti-autoimmune or blood-purifying therapy should be given in time. Furthermore, effective isolation measures and appropriate psychological comfort need to be provided timely.

Clinical Features of a COVID-19 Ward for Children and Investigation of Inpatient Pharmaceutical Services for Pediatric COVID-19 Patients

Global Pediatric Pulmonology Alliance (GPPA) proposal for COVID-19 vaccination in children

Take Precautions Beforehand: Calling for Clinical Trials of Pediatric Drugs for Treating Coronavirus Disease 2019.

Pharmacotherapeutic Options for Children with COVID-19: a Narrative Review

[Diagnosis and Treatment Recommendation for Pediatric COVID-19 (the Second Edition)].

Management Experience of a Designated Hospital for Children with Coronavirus Disease 2019.

A Mini Review on Current Clinical and Research Findings for Children Suffering from COVID-19

Childhood COVID-19: a Multicentre Retrospective Study

Assessing the Clinical Characteristics and Management of COVID-19 among Pediatric Patients in Ghana: Findings and Implications

Advices on the Prevention and Control of Nosocomial Infection of Novel Coronavirus Within Children’s Hospitals

Advices on the prevention and control of nosocomial infection of COVID-19 within children′s hospitals

Discussions on the Emergency Medical Procedure of Children′s Hospitals Against COVID-19 Epidemic

Epidemiological and clinical features of pediatric COVID-19

Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives

The clinical and immunological features of pediatric COVID-19 patients in China

Preisolation measures and clinical features for pediatric patients with suspicious COVID-19

Economic value and characteristics of cloud pharmacy for children based on internet hospital in western China during the COVID-19 pandemic: Cross-sectional survey study

Clinical Experiences in the Management of Critically Ill Patients with COVID-19 in a Designated Children's Hospital in China

An Overview of Pediatric Pulmonary Complications During COVID‐19 Pandemic: A Lesson for Future

Clinical Features and Outcomes of Pediatric and Adult Patients Hospitalized for Coronavirus Disease 2019: A Comparison Across Age Strata

COVID-19 in 7780 pediatric patients: A systematic review